Study Site 15 — Houston, Texas

Public research footprint of Study Site 15, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Rheumatoid Arthritis · Plaque Psoriasis · Severe Hypertriglyceridemia · COVID-19

Recently updated registry entries

NCT07116967 — Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With… (Recruiting)
NCT05852431 — To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe… (Completed)
NCT03915964 — A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Study Site 15?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.